Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerPolicy UpdatesReimbursement/Payment PolicyUniversity Health Alliance wound care Coverage | O…
    Ask Trek AI about this page
    CurrentUniversity Health Alliance (HSA)Policy MPP-0129-190618

    Cellulitis and Chronic/Complex Wound Care Reimbursement Policy

    Customize your policy alerts

    Sign up for University Health Alliance (HSA) Policy MPP-0129-190618 alerts

    Get alerted when Policy MPP-0129-190618 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines UHA reimbursement and medical necessity criteria for evaluation, management, and treatment of skin cellulitis, chronic and complex wounds (including related diagnostics, consultations, and place-of-service decisions) for University Health Alliance members.

    Policy Summary
    PayerUniversity Health Alliance (HSA)
    PolicyCellulitis and Chronic/Complex Wound Care Reimbursement Policy
    Policy CodePolicy MPP-0129-190618
    Change TypeNo material changes
    Effective DateAug 1, 2022
    Last ReviewAug 1, 2022
    Next Review Date
    Key ActionPrior authorization is not required.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    Not requiredprior auth
    Hospital/SNF coveredplace of service
    Covered (systemic signs)parenteral antibiotics
    Not routinely coveredantibiotic exclusion

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Adjuncts only
    adjunct therapies

    Medical Necessity and Coverage Criteria

    Medical Necessity Criteria

    Covered when ALL of the following documentation, evaluation, and wound‑specific criteria are met:

    ALL of the following

    • A comprehensive treatment plan must address systemic disease, goals for rehabilitation, and prevention of recurrent infection and/or breakdown. Treatment of predisposing factors (e.g., edema, underlying cutaneous disorders, interdigital toe pathology) is required.
    • Failure to document consideration and treatment of applicable comorbidities, etiologic conditions, and social/domestic factors (e.g., recurrent insect bites, poor hygiene, inaccessibility to treatment) may prompt requests for information and can lead to denial if standards of care are not met.
    • Outpatient examinations must permit assessment of improvement or progression; documentation should include measurements, dressing inspection, edema, erythema, drainage, and circulation. Photographs may be helpful but do not replace clinical documentation.

    ALL of the following

    • Address diabetes and other systemic diseases; adequate glycemic control is a priority when treating wounds and infections.
    • For recurrent cellulitis, identify and treat predisposing conditions such as edema, obesity, diabetes, arterial and small vessel disease, dermatitis/eczema, venous insufficiency, and toe web abnormalities. Documentation of these steps is required for claims review.

    ALL of the following

    • Appropriate wound care includes irrigation; debridement (with documentation of adequacy and surgeon assessment of viability of bone/tendon/cartilage); topical therapy; dressings; wound packing; and wound closure.
    • Negative pressure wound therapy, skin grafts, adjunct therapies, and hyperbaric oxygen therapy may be used when appropriate; adjuncts (e.g., wound vacs, bioengineered dressings) are NOT substitutes for mechanical debridement and frequent wound inspection.
    • When surgical management is indicated, follow a step‑wise approach (incision, wound investigation, complete debridement, irrigation/lavage, and definitive closure) with documentation of decisions regarding amputation or closure and frequency/extent of debridement.

    ALL of the following

    • Laboratory and culture indications: Laboratory testing and cultures are not routinely required for uncomplicated infections; cultures of blood or cutaneous specimens are medically necessary only for complicating circumstances (e.g., severe/local extensive infection, systemic signs such as fever, immunosuppression, malignancy on chemotherapy, neutropenia, failure of initial therapy, extremes of age, special exposures, or when community organism susceptibility is unknown).
    • Imaging: Radiographic testing (ultrasound to detect abscess, MRI to distinguish osteomyelitis) may be necessary for suspected abscess, osteomyelitis, persistent systemic symptoms, immunosuppression, diabetes, venous insufficiency, lymphedema, or suspected radio‑opaque foreign body; imaging must not delay urgent surgical intervention when necrotizing infection is suspected.
    • Specialty consultation: Consultation with dermatology, radiology, surgery, infectious disease, vascular surgery, and other specialists is medically necessary on a case‑by‑case basis for complex, unusual, or recurrent infections and is encouraged early for refractory disease.

    ALL of the following

    • Parenteral antibiotics are medically necessary for cellulitis with systemic signs of infection; choice of agent should conform to community standard of care and may require infectious disease or pharmacy consultation for atypical presentations or recurrent disease.
    • Parenteral antibiotics are NOT medically necessary for typical cellulitis without systemic signs in most instances. UHA will not routinely cover antibiotics for bilateral lower‑leg swelling and redness unless clear evidence of infection is documented; clinicians must consider alternative diagnoses to avoid misdiagnosis and unnecessary therapy.
    • Prophylactic antibiotics consideration: Consider prophylactic antibiotics when appropriate for patients who have 3 to 4 episodes of cellulitis per year despite attempts to treat or control predisposing factors.

    ALL of the following

    • Inpatient care may be medically necessary for suspected deeper or necrotizing infection, severe immunocompromise, poor adherence, or failing outpatient therapy; documentation of medical reasoning must meet medical necessity and be available on request. Direct communication with UHA clinical staff is required when admitting providers suspect a member may benefit from admission but may not meet standard admission requirements.
    • Inpatient or SNF care may be necessary for patients at high risk for noncompliance or poor outcomes due to comorbidities or social factors. Referral to a certified wound care center is medically necessary for complex conditions (e.g., arterial ulcers, diabetic foot ulcers, refractory lower extremity cellulitis/edema, neuropathic ulcers, pressure ulcers, necrotizing infections, venous ulcers).

    ALL of the following

    • Necrotizing infections are characterized by fulminant tissue destruction and systemic toxicity; prompt surgical referral and early surgical intervention with antibiotics are medically necessary.
    • Conditions such as Meleney ulcer and pyoderma gangrenosum require additional specialty consultation and documentation; pyoderma gangrenosum is not an infectious process and often relates to underlying systemic disease.
    • Appropriate tetanus toxoid immunization is medically necessary for all open wounds and should be administered as indicated.

    ALL of the following

    • Claims for recurrent cellulitis may be pended for review; documentation should include identification and treatment of predisposing conditions, consideration of prophylactic antibiotics when appropriate, consultation with relevant specialties, and documentation of social/domestic causes. Lack of such documentation may result in denial.

    Covered Services and Coding Guidance

    inv-03: Consider prophylactic antibiotics
    Prophylactic antibiotics thresholdConsider prophylactic antibiotics for patients who have 3 to 4 episodes of cellulitis per year despite attempts to treat or control predisposing factors.
    Documentation required for recurrent cellulitisClaims may be pended for review; document identification and treatment of predisposing conditions (edema, obesity, diabetes, arterial/small vessel disease, dermatitis, eczema, venous insufficiency, toe web abnormalities).
    Assessment of social/domestic causesIdentify and document social/domestic contributors (recurrent insect bites, poor hygiene, inaccessibility to prescribed treatment).
    Outpatient examination standardsOutpatient visit documentation must demonstrate degree of improvement or progression; include measurements, dressing inspection, edema, erythema, drainage, circulation; photographs may be helpful but do not replace clinical documentation.

    Prior Authorization, Admission Communication, and Claim Review

    Prior Authorization

    Prior authorization not required

    Prior authorization is not required for services covered under this policy.

    Documentation Required

    Contact UHA before admitting when eligibility is uncertain

    When admitting a member for cellulitis or complex wound care and the provider suspects the admission may benefit the member but might not meet standard admission requirements, the provider must directly communicate with UHA clinical staff at 808-532-4006 prior to admission.

    Key Definitions

    inv-07: Complex/Chronic Wounds
    Examples of complex/chronic woundsDiabetic ulcers (neuropathic and other), chronic venous ulcers, wounds associated with arterial insufficiency, and wounds from systemic diseases such as vasculitis.
    Care expectationsUHA expects comprehensive, coordinated, step-wise care for severe or refractory wounds and those with comorbid conditions; hospitalization may be appropriate when indicated.
    Adjuncts vs. standard careAdjunct therapies (e.g., hyperbaric oxygen, bioengineered skin substitutes, negative pressure therapy) may apply in defined circumstances but are not substitutes for standard treatment such as debridement and inspection.
    Need for specialist involvementPatients with complex or refractory wounds often require coordinated care and frequent surveillance by knowledgeable specialists to achieve long-term healing.
    inv-08: Necrotizing soft tissue infection
    Policy Summary
    PayerUniversity Health Alliance (HSA)
    PolicyCellulitis and Chronic/Complex Wound Care Reimbursement Policy
    Policy CodePolicy MPP-0129-190618
    Change TypeNo material changes
    Effective DateAug 1, 2022
    Last ReviewAug 1, 2022
    Next Review Date
    Key ActionPrior authorization is not required.
    SourceLink
    On This Page
    Medical Necessity and Coverage CriteriaCovered Services and Coding GuidancePrior Authorization, Admission Communication, and Claim ReviewKey Definitions
    Denial Risk

    Prepare documentation for potential pend/medical necessity review of recurrent cellulitis

    Claims for recurrent cellulitis may be pended for medical necessity review; providers should document identification and treatment of predisposing conditions and provide requested consultations and outpatient assessment documentation.

    • Document identification and treatment of predisposing conditions (e.g., edema, obesity, diabetes, arterial/small vessel disease, dermatitis, venous insufficiency, toe web abnormalities).
    • Consider and document prophylactic antibiotics when the patient has 3–4 episodes of cellulitis per year despite control of predisposing factors.
    • Provide documentation of consultations (e.g., infectious disease, vascular surgery) as applicable.
    • Include outpatient visit documentation that allows assessment of improvement or progression (measurements, dressings, edema, erythema, drainage); photographs may be helpful but do not replace clinical documentation.
    Definition
    Necrotizing soft tissue infections are fulminant infections characterized by rapid tissue destruction, systemic signs of toxicity, and high mortality.
    Required managementAccurate diagnosis and appropriate treatment require early surgical intervention and antibiotic therapy; prompt surgical referral is considered medically necessary.
    Examples and urgencyIncludes conditions such as Fournier gangrene; these infections demand urgent evaluation and operative management rather than delayed imaging when suspected.